Get started
Author

Purav Desai

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Eugenia Abaleke, Mustafa Abbas, et al. · The Lancet · 533
PDF
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 493
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 369
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 324
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 290
Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19
2021 · Hesham Abdelhady, Marwa Abdelrazik, et al. · JAMA · 210
PDF
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · RECOVERY Collaborative Group, Peter W Horby, et al. · medRxiv · 143
PDF
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 129
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39
PDF
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12
PDF
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O. Abani, A. Abbas, et al. · EClinicalMedicine · 5
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · Peter W Horby, Natalie Staplin, et al. · medRxiv · 5
PDF
Molnupiravir or nirmatrelvir-ritonavir versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2024 · RECOVERY Collaborative Group, Peter W Horby, et al. · medRxiv · 4
Sotrovimab versus usual care in patients admitted to hospital with COVID-19: a randomised, controlled, open-label, platform trial (RECOVERY)
2025 · Peter W Horby, Jonathan R Emberson, et al. · medRxiv · 2
PDF
Venous Thromboembolism (VTE) in May-Thurner Syndrome: Decision-Making Related to Long-Term Anticoagulation
2024 · Aishwarya Krishnan, Purav Desai · Cureus · 2
PDF
Posterior Reversible Encephalopathy Syndrome: ‘A headache’ on the AMU
2013 · Huddersfield Royal Infirmary, Purav Desai, et al. · Acute Medicine Journal · 1
Acute Fulminant Necrotizing Amoebic Colitis: A potentially fatal cause of diarrhoea on the Acute Medical Unit
2011 · Purav Desai, Nurani Sivaramakrishnan · Acute Medicine Journal · 1
Proposing a Coverage With Evidence Development Framework for Accelerated Approval at the U.S. Food and Drug Administration
2026 · Dhanush Bearelly, Purav Desai, et al. · Pharmacoepidemiology and Drug Safety
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases
PDF
In-hospital Outcomes of Out of Hospital Cardiac Arrest Survivors Treated With Targeted Temperature Management. a Propensity Matched Cohort Analysis
2024 · Endurance O. Evbayekha, Antoine Kharsa, et al. · Journal of the American College of Cardiology
Abstract 16523: Trends and Outcomes of Preeclampsia Hospitalizations According to the Nationwide Inpatient Sample 2016-2020; An Updated Retrospective Population-Based Study
2023 · Endurance O Evbayekha, Yara Jelwan, et al. · Circulation
Abstract 12600: COVID-19 Hospitalizations With and Without Pulmonary Hypertension: An Analysis of the 2020 Nationwide Inpatient Database
2023 · Endurance O Evbayekha, Yara Jelwan, et al. · Circulation
Abstract 16383: The Burden of Cardio-Metabolic Disorders Among the Hospitalized Population With Renovascular Hypertension and Predictors of Mortality; a Population-Based Retrospective Study
2023 · Endurance O Evbayekha, Leonela Bastidas, et al. · Circulation
Abstract 16081: Cardiovascular Outcomes of Individuals With Sleep Deprivation; a Retrospective Population-Based Analysis
2023 · Endurance O Evbayekha, Carlos Gaibor, et al. · Circulation
Works count: 30
Citation count: 2,602
H-index: 11
I10-index: 11
Year
Topic
Type